Isocorydine Targets the Drug-Resistant Cellular Side Population through PDCD4-Related Apoptosis in Hepatocellular Carcinoma

Isocorydine (ICD), an anticancer agent under current evaluation, decreased the percentage of side population (SP) cells significantly in hepatocellular carcinoma (HCC) cell lines. ICD treatment sensitized cancer cells to doxorubicin (DXR), a conventional clinical chemotherapeutic drug for HCC. We fo...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Lu, Ping, Sun, Hefen, Zhang, Lixing, Hou, Helei, Zhang, Lin, Zhao, Fangyu, Ge, Chao, Yao, Ming, Wang, Tingpu, Li, Jinjun
Formato: Artigo
Idioma:Inglês
Publicado em: ScholarOne 2012
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3474433/
https://ncbi.nlm.nih.gov/pubmed/22714713
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2119/molmed.2012.00055
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados